ACADEMIC INFORMATION AND ADMISSIONS

Credits - 70 / European ECTS credits

Pre-selection process: Open

Inscriptions: from October 2019 to August 2020

Master Program – October 2020 to June 2021.

Full Time - Monday to Thursday from 18:00h. to 21:00h.

Language - English

Limited Places

MASTER'S OBJECTIVE

The objective of the program is to understand the relationship and different agreements negotiation processes between biotechnology-based companies and pharmaceutical companies in new compound acquisitions. The main skills and topics are related with international business development, portfolio increase, new valuation compounds, deal terms and conditions, milestones and royalties, and the negotiation process.

PROFESIONAL DEVELOPMENT

The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers. 

ACADEMIC PROGRAMME

I. Global Ecosystem in Drug Discovery

II. Scientific and Regulatory Developemt

III. Profesional and Personal Leadership

IV. Portfolio Management

V. Global Marketing

VI. Master's Thesis - Licensing Agreement and Acquisition

See the full Academic Programme

MASTER'S DEGREE

The Students that pass the master program  evaluation will receive a double titulation from the Univerisity of Barcelona and the Biotechnology Business Institute in Master in Business Administration in LifeScience with metntion in International Business Development.

                


 

Information request